GMO Beyond China ETF (NYSEARCA:BCHI) Short Interest Update

GMO Beyond China ETF (NYSEARCA:BCHI) was the target of a significant drop in short interest in February. As of February 13th, there was short interest totaling 28,674 shares, a drop of 65.4% from the January 29th total of 82,944 shares. Approximately 7.2% of the company’s stock are short sold. Based on an average daily volume of 4,270 shares, the short-interest ratio is presently 6.7 days. Based on an average daily volume of 4,270 shares, the short-interest ratio is presently 6.7 days. Approximately 7.2% of the company’s stock are short sold.

Institutional Investors Weigh In On GMO Beyond China ETF

A hedge fund recently bought a new stake in GMO Beyond China ETF stock. Lazard Asset Management LLC purchased a new stake in shares of GMO Beyond China ETF (NYSEARCA:BCHI) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 20,851 shares of the company’s stock, valued at approximately $570,000. Lazard Asset Management LLC owned 5.21% of GMO Beyond China ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

GMO Beyond China ETF Price Performance

Shares of BCHI stock traded down $0.21 on Friday, hitting $35.55. 1,113 shares of the stock traded hands, compared to its average volume of 4,349. The company’s fifty day moving average is $32.62 and its 200 day moving average is $30.60. GMO Beyond China ETF has a 1-year low of $21.81 and a 1-year high of $35.86. The company has a market capitalization of $14.22 million, a PE ratio of 14.75 and a beta of 1.37.

About GMO Beyond China ETF

The GMO Beyond China ETF (BCHI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed to invest in equity securities of any market capitalization from emerging markets, with the exemption of China. BCHI was launched on Feb 12, 2025 and is issued by GMO.